• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

国家 HPV 疫苗接种计划实施后青少年复发性呼吸道乳头瘤病发病率的前瞻性研究。

A Prospective Study of the Incidence of Juvenile-Onset Recurrent Respiratory Papillomatosis After Implementation of a National HPV Vaccination Program.

机构信息

University of Sydney Medical School, University of Sydney and Kids Research Institute, Sydney Children's Hospitals Network (Westmead).

ENT Department, Children's Hospital Westmead, University of Sydney and Kids Research Institute, Sydney Children's Hospitals Network (Westmead).

出版信息

J Infect Dis. 2018 Jan 4;217(2):208-212. doi: 10.1093/infdis/jix498.

DOI:10.1093/infdis/jix498
PMID:29136168
Abstract

BACKGROUND

Recurrent respiratory papillomatosis is a rare but morbid disease caused by human papillomavirus (HPV) types 6 and 11. Infection is preventable through HPV vaccination. Following an extensive quadrivalent HPV vaccination program (females 12-26 years in 2007-2009) in Australia, we established a method to monitor incidence and demographics of juvenile-onset recurrent respiratory papillomatosis (JORRP) cases.

METHODS

The Australian Paediatric Surveillance Unit undertakes surveillance of rare pediatric diseases by contacting practitioners monthly. We enrolled pediatric otorhinolaryngologists and offered HPV typing. We report findings for 5 years to end 2016.

RESULTS

The average annual incidence rate was 0.07 per 100000. The largest number of cases was reported in the first year, with decreasing annual frequency thereafter. Rates declined from 0.16 per 100000 in 2012 to 0.02 per 100000 in 2016 (P = .034). Among the 15 incident cases (60% male), no mothers were vaccinated prepregnancy, 20% had maternal history of genital warts, and 60% were first born; 13/15 were born vaginally. Genotyped cases were HPV-6 (n = 4) or HPV-11 (n = 3).

CONCLUSION

To our knowledge, this is the first report internationally documenting decline in JORRP incidence in children following a quadrivalent HPV vaccination program.

摘要

背景

复发性呼吸道乳头瘤病是一种罕见但严重的疾病,由人乳头瘤病毒(HPV)型 6 和 11 引起。通过 HPV 疫苗接种可以预防感染。在澳大利亚广泛开展四价 HPV 疫苗接种计划(2007-2009 年为 12-26 岁女性)后,我们建立了一种监测青少年复发性呼吸道乳头瘤病(JORRP)病例发病率和人口统计学特征的方法。

方法

澳大利亚儿科监测单位每月与医生联系,开展罕见儿科疾病监测。我们招募了儿科耳鼻喉科医生,并提供 HPV 分型。我们报告了截至 2016 年底的 5 年发现结果。

结果

平均年发病率为每 10 万人 0.07 例。报告的病例数量最多的是第一年,此后每年的频率逐渐降低。发病率从 2012 年的每 10 万人 0.16 例降至 2016 年的每 10 万人 0.02 例(P =.034)。在 15 例新发病例(60%为男性)中,没有母亲在妊娠前接种疫苗,20%的母亲有生殖器疣病史,60%为第一胎,13/15 为阴道分娩。HPV 型别为 HPV-6(n = 4)或 HPV-11(n = 3)。

结论

据我们所知,这是首次在国际上报道四价 HPV 疫苗接种计划后儿童 JORRP 发病率下降的报告。

相似文献

1
A Prospective Study of the Incidence of Juvenile-Onset Recurrent Respiratory Papillomatosis After Implementation of a National HPV Vaccination Program.国家 HPV 疫苗接种计划实施后青少年复发性呼吸道乳头瘤病发病率的前瞻性研究。
J Infect Dis. 2018 Jan 4;217(2):208-212. doi: 10.1093/infdis/jix498.
2
Significant Declines in Juvenile-onset Recurrent Respiratory Papillomatosis Following Human Papillomavirus (HPV) Vaccine Introduction in the United States.人乳头瘤病毒(HPV)疫苗在美国引入后,青少年复发性呼吸道乳头瘤病显著减少。
Clin Infect Dis. 2021 Sep 7;73(5):885-890. doi: 10.1093/cid/ciab171.
3
Juvenile-Onset Recurrent Respiratory Papillomatosis in the United States, Epidemiology and HPV Types-2015-2020.美国青少年复发性呼吸道乳头瘤病的流行病学和 HPV 型别-2015-2020。
J Pediatric Infect Dis Soc. 2021 Aug 17;10(7):774-781. doi: 10.1093/jpids/piab016.
4
Assessing genital human papillomavirus genoprevalence in young Australian women following the introduction of a national vaccination program.在澳大利亚实施全国性疫苗接种计划后,评估年轻澳大利亚女性中生殖器人乳头瘤病毒的基因型流行情况。
Vaccine. 2015 Jan 1;33(1):201-8. doi: 10.1016/j.vaccine.2014.10.045. Epub 2014 Nov 1.
5
Human papillomavirus types causing recurrent respiratory papillomatosis in Zimbabwe.在津巴布韦导致复发性呼吸道乳头状瘤病的人乳头瘤病毒类型。
Int J Pediatr Otorhinolaryngol. 2019 Jan;116:147-152. doi: 10.1016/j.ijporl.2018.10.036. Epub 2018 Oct 26.
6
Forecasting Disease Burden with a Dynamic Transmission Model of Human Papillomavirus and Recurrent Respiratory Papillomatosis in the United States.美国基于人乳头瘤病毒和复发性呼吸道乳头瘤病动态传播模型的疾病负担预测。
Viruses. 2024 Aug 11;16(8):1283. doi: 10.3390/v16081283.
7
The incidence of genital warts in Australian women prior to the national vaccination program.在全国疫苗接种计划实施之前,澳大利亚女性尖锐湿疣的发病率。
Sex Health. 2009 Sep;6(3):178-84. doi: 10.1071/SH08079.
8
Estimating the prevalence of and treatment patterns for juvenile onset recurrent respiratory papillomatosis in Australia pre-vaccination: a pilot study.澳大利亚疫苗接种前青少年复发性呼吸道乳头状瘤病的患病率及治疗模式估计:一项试点研究。
Sex Health. 2010 Sep;7(3):253-61. doi: 10.1071/SH09142.
9
Quadrivalent vaccine-targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a retrospective observational study.澳大利亚女性 HPV 疫苗接种计划后异性恋男性中四价疫苗针对的人乳头瘤病毒基因型:一项回顾性观察研究。
Lancet Infect Dis. 2017 Jan;17(1):68-77. doi: 10.1016/S1473-3099(16)30116-5. Epub 2016 Jun 6.
10
Human papillomavirus in young women with Chlamydia trachomatis infection 7 years after the Australian human papillomavirus vaccination programme: a cross-sectional study.澳大利亚人乳头瘤病毒疫苗接种计划 7 年后沙眼衣原体感染的年轻女性中的人乳头瘤病毒:一项横断面研究。
Lancet Infect Dis. 2015 Nov;15(11):1314-23. doi: 10.1016/S1473-3099(15)00055-9. Epub 2015 Jul 19.

引用本文的文献

1
Accelerating HPV-related cancer elimination - a meeting report.加速消除与人类乳头瘤病毒相关的癌症——会议报告
BMC Proc. 2025 Aug 29;19(Suppl 19):22. doi: 10.1186/s12919-025-00337-1.
2
PRGN-2012 gene therapy in adults with recurrent respiratory papillomatosis: a pivotal phase 1/2 clinical trial.PRGN-2012基因疗法用于复发性呼吸道乳头状瘤病成人患者:一项关键的1/2期临床试验。
Lancet Respir Med. 2025 Apr;13(4):318-326. doi: 10.1016/S2213-2600(24)00368-0. Epub 2025 Jan 21.
3
"A systematic literature review of the epidemiology, clinical, economic and humanistic burden in recurrent respiratory papillomatosis".
复发性呼吸道乳头状瘤病的流行病学、临床、经济和人文负担的系统文献综述
Respir Res. 2024 Dec 18;25(1):430. doi: 10.1186/s12931-024-03057-w.
4
Awareness, attendance, and attitudes toward cervical cancer screening among HIV-positive Chinese women in Yunnan province: a cross-sectional study.云南省HIV阳性中国女性对宫颈癌筛查的认知、参与情况及态度:一项横断面研究
BMC Womens Health. 2024 Dec 4;24(1):636. doi: 10.1186/s12905-024-03478-1.
5
Forecasting Disease Burden with a Dynamic Transmission Model of Human Papillomavirus and Recurrent Respiratory Papillomatosis in the United States.美国基于人乳头瘤病毒和复发性呼吸道乳头瘤病动态传播模型的疾病负担预测。
Viruses. 2024 Aug 11;16(8):1283. doi: 10.3390/v16081283.
6
Human Papilloma Virus Vaccines and Vaccination.人乳头瘤病毒疫苗与接种
Turk Arch Pediatr. 2024 May 2;59(3):234-237. doi: 10.5152/TurkArchPediatr.2024.03024.
7
Intralesional Bevacizumab as Adjuvant Therapy for Juvenile Onset Recurrent Respiratory Papillomatosis: A Systematic Review.病灶内注射贝伐单抗作为青少年复发性呼吸道乳头状瘤病的辅助治疗:一项系统评价
Indian J Otolaryngol Head Neck Surg. 2023 Jun;75(2):1296-1301. doi: 10.1007/s12070-022-03204-z. Epub 2022 Nov 6.
8
Systemic bevacizumab for pediatric patients with aggressive recurrent respiratory papillomatosis: One single-center experience of eight patients.贝伐单抗全身治疗侵袭性复发性呼吸道乳头状瘤病患儿:单中心8例患者的经验
Laryngoscope Investig Otolaryngol. 2023 Feb 9;8(2):435-440. doi: 10.1002/lio2.1013. eCollection 2023 Apr.
9
Recurrent Respiratory Papillomatosis (RRP)-Meta-analyses on the use of the HPV vaccine as adjuvant therapy.复发性呼吸道乳头状瘤病(RRP)——关于使用人乳头瘤病毒(HPV)疫苗作为辅助治疗的荟萃分析。
NPJ Vaccines. 2023 Apr 1;8(1):49. doi: 10.1038/s41541-023-00644-8.
10
Assessment of Acceptability and Determinants of Uptake and Schedule Completion of Human Papillomavirus (HPV) Vaccine by 25 to 45 Years Old Women in Slovenia.斯洛文尼亚25至45岁女性对人乳头瘤病毒(HPV)疫苗的可接受性、接种率及接种计划完成情况的评估及影响因素分析
Vaccines (Basel). 2023 Feb 12;11(2):423. doi: 10.3390/vaccines11020423.